Home » Newsletters » BioWorld Science

BioWorld Science

April 25, 2005

View Archived Issues

Ondansetron reported to improve memory function in schizophrenia

Trabectedin shows antitumor activity in relapsed or refractory ovarian carcinoma

Corlux prevents olanzapine-induced weight gain in rats

Enrollment completed in phase III study of Thymitaq for HCC

A new immunostimulat from intestinal Eimeria

Early termination of phase III study of gefitinib for advanced lung cancer

Debiopharm and NanoCarrier form platinum compound research collaboration

Shire to acquire Transkaryotic Therapies

Trexima achieves endpoints in second phase III trial

Progression of pivotal study of MBP-8298 for secondary progressive MS

Evaluation of peptide deformylase inhibitor LBM-415's antimicrobial activity / News in Context

ST-294: Orally bioavailable small-molecule antiviral agent for New World Arenaviruses

Preclinical results from lead smallpox drug ST-246

BioCurex's RECAF blood test detects 92% of cervical cancers

Guilford restarts Aquavan program

SX-007 prolongs survival of mice with glioblastoma

FXa inhibitor reduces metastasis without anticoagulant-associated side effects

New patents cover treatments for cancer

Agreement on label wording for 5 mg dose of Crestor in Europe

MP-412: a promising compound for the treatment of EGFR/HER2-expressing tumors

Positive opinion handed down in Europe for new Temodal indication

Preclinical studies demonstrate that CYT-997 is a promising antitumor candidate

Preclinical antitumor activity of phase I PharmaMar compound

Eisai synthesizes novel antimitotic agent related to hemiasterlin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.